PeptideDB

Dehydrocorydaline (hydroxyl)

CAS: F: C22H25NO5 W: 383.44

Dehydrocorydaline (13-Methylpalmatine) hydroxyl is an alkaloid that regulates protein expression of Bax, Bcl-2; activate
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Dehydrocorydaline (13-Methylpalmatine) hydroxyl is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline hydroxyl elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline hydroxyl shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90%) using P. falciparum 3D7 strain[3].
Invitro Dehydrocorydaline hydroxy (0-200 μM) 处理以剂量依赖性方式显着抑制 MCF-7 细胞的生长。200 μM Dehydrocorydaline hydroxyl 处理 24 小时后,细胞活力降低了约 40%[1]。Dehydrocorydaline hydroxyl (0-200 μM) 剂量依赖性地增加 Bax 蛋白表达并降低 Bcl-2 蛋白表达[1]。Dehydrocorydaline hydroxyl (0-200 μM) 诱导 caspase-7,-8 的激活和 PARP 的裂解而不影响 caspase-9[1]。
In Vivo Dehydrocorydaline hydroxy 表现出低急性毒性,小鼠口服的 LD50 约为 277.5±19.0 mg/kg 体重,腹腔注射为 21.1±1.4 mg/kg[4]。
Name Dehydrocorydaline (hydroxyl)
Formula C22H25NO5
Molar Mass 383.44
Appearance Solid
Transport Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Reference [1]. Xu Z, et al. Dehydrocorydaline inhibits breast cancer cells proliferation by inducing apoptosis in MCF-7 cells. Am J Chin Med. 2012;40(1):177-85. [2]. Yoo M, et al. Dehydrocorydaline promotes myogenic differentiation via p38 MAPK activation. Mol Med Rep. 2016 Oct;14(4):3029-36. [3]. Nonaka M, et al. Screening of a library of traditional Chinese medicines to identify anti-malarial compounds and extracts. Malar J. 2018 Jun 25;17(1):244. [4]. Yin ZY, et al. Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines. Sci Rep. 2016 Jun 7;6:27129.